GoodRx Holdings Inc (NASDAQ: GDRX) is 21.64% higher on its value in year-to-date trading and has touched a low of $4.14 and a high of $9.26 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GDRX stock was last observed hovering at around $8.23 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $8.15, the stock is 3.91% and 1.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing -0.97% at the moment leaves the stock 16.31% off its SMA200. GDRX registered 36.06% gain for a year compared to 6-month gain of 24.62%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.91% loss in the last 1 month and extending the period to 3 months gives it a 14.15%, and is 9.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.05% over the week and 5.89% over the month.
GoodRx Holdings Inc (GDRX) has around 694 employees, a market worth around $3.09B and $775.09M in sales. Fwd P/E is 18.52. Profit margin for the company is -7.57%. Distance from 52-week low is 97.10% and -11.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.30%).
with sales reaching $195.65M over the same period.The EPS is expected to grow by 24.07% this year, but quarterly earnings will post 6.70% year-over-year. Quarterly sales are estimated to grow 8.70% in year-over-year returns.
GoodRx Holdings Inc (GDRX) Top Institutional Holders
217.0 institutions hold shares in GoodRx Holdings Inc (GDRX), with institutional investors hold 160.94% of the company’s shares. The shares outstanding are 92.36M, and float is at 80.78M with Short Float at 9.73%. Institutions hold 140.48% of the Float.
The top institutional shareholder in the company is FRANCISCO PARTNERS MANAGEMENT, LP with over 70.08 million shares valued at $546.61 million. The investor’s holdings represent 17.9666% of the GDRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.13 million shares valued at $63.43 million to account for 2.0849 of the shares outstanding. The other top investors are AMERIPRISE FINANCIAL INC which holds 5.18 million shares representing 1.3287% and valued at over $40.42 million, while MILLENNIUM MANAGEMENT LLC holds 1.0568 of the shares totaling 4.12 million with a market value of $32.15 million.
GoodRx Holdings Inc (GDRX) Insider Activity
The most recent transaction is an insider sale by Nabiey Romin, the company’s Chief Accounting Officer. SEC filings show that Nabiey Romin sold 79,000 shares of the company’s common stock on Aug 12 ’24 at a price of $6.77 per share for a total of $0.53 million. Following the sale, the insider now owns 64633.0 shares.
Still, SEC filings show that on Nov 30 ’23, Wagner Scott () acquired 21,652 shares at an average price of $5.76 for $0.12 million. The insider now directly holds 182,900 shares of GoodRx Holdings Inc (GDRX).
